Portrait of Newhouse, Dan

Newhouse, Dan

U.S. Representative WA-4 Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
212
Buys / sells
54% / 46%
Last trade
Jul 10, 2026
Last filing
Jul 17, 2026

Latest disclosed trades

Latest 10 of 212
Ticker Type Traded
UBER Buy Jul 10, 2026
FMC Sell Jul 10, 2026
FTNT Sell Jul 10, 2026
NVDA Sell Jul 10, 2026
UPS Sell Jul 10, 2026
MS Buy Jul 10, 2026
FIS Buy Jul 10, 2026
HSY Sell Jul 10, 2026
MPC Sell Jul 10, 2026
AMAT Sell Jul 10, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Newhouse, Dan stock trade activity

FilingIQ has indexed 212 congressional stock trade disclosures for Newhouse, Dan. The most recent disclosed transaction is dated Jul 10, 2026.

Across the full history, 114 purchases and 97 sales have been disclosed under the STOCK Act.

Top tickers traded by Newhouse, Dan

Frequently asked

How many stock trades has Newhouse, Dan disclosed?
FilingIQ tracks 212 Periodic Transaction Report disclosures for Newhouse, Dan, with the most recent dated Jul 10, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Newhouse, Dan a net buyer or net seller?
Across the disclosed trade history, 114 (54%) were purchases and 97 (46%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Newhouse, Dan come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.